The Australian Society for Medical Research (ASMR) has announced Professor Fabienne Mackay as the 2026 ASMR Medallist, recognising her exceptional contributions to immunology research and medical research leadership.
Professor Mackay’s research fundamentally changed our understanding of autoimmune diseases. Working first at BiogenIdec in the United States and later in Australia, she co-discovered BAFF (B cell-activating factor) and was the first to demonstrate its critical role in driving lupus and other autoimmune conditions.
This foundational work led to the development of belimumab (Benlysta™), which was approved by the FDA in 2011 as the first new treatment for systemic lupus erythematosus in over 50 years. The drug is now used by lupus patients globally.
“Professor Mackay’s work exemplifies the journey from basic discovery to patient benefit,” said Dr Shane Huntington OAM, ASMR CEO. “Her research not only advanced our scientific understanding but translated into a therapy that has changed lives.”
Professor Mackay’s contributions extend far beyond a single discovery. With over 26,000 citations and an h-index of 76, she is among the world’s most influential researchers in her field. She has published extensively on the BAFF/APRIL system and its role in B cell biology, autoimmunity, and cancer.
Born in France, Professor Mackay completed her PhD in Immunology at the Université Louis Pasteur before joining the Basel Institute for Immunology in Switzerland and later BiogenIdec in Cambridge, Massachusetts.
She moved to Australia in 2000, establishing her research program at the Garvan Institute of Medical Research before taking on leadership positions at Monash University and the University of Melbourne.
Most recently, Professor Mackay served as Director and CEO of QIMR Berghofer Medical Research Institute in Brisbane from 2020 to 2025. During her tenure, she doubled research funding, improved NHMRC success rates from 7% to 20%, and achieved over $168 million in commercial revenues.
She is currently an Emeritus Fellow at QIMR Berghofer and holds honorary professorships at the Universities of Queensland and Melbourne and Monash University.
Professor Mackay is a Fellow of the Australian Academy of Health and Medical Sciences and the Queensland Academy of Arts and Sciences. In 2025, she received the NHMRC Ethics and Integrity Award.
Professor Mackay will deliver the ASMR Medallist Address at the National Press Club in Canberra and at our Gala Dinners across Australia during ASMR Medical Research Week® 2026, which runs from 23-30 October.
“We’re honoured to recognise Professor Mackay’s achievements,” Dr Huntington said. “She brings exceptional scientific credibility, leadership experience, and a compelling ability to communicate why medical research matters.”
